Neurological diseases directly or indirectly affect almost all Finns, as well as millions of people worldwide. Finland’s research in neuroscience and related product development are of excellent quality and adhere to high international standards; this expertise is therefore highly respected.
One of the main reasons for the neuroscience success story in Finland has been the voluntary participation of Finnish citizens in the development of drugs and treatments, either by donating specimens and samples or as participants in clinical trials. This has enabled the development of new therapies.
The current goal is to develop yet more targeted treatments for various neurological diseases. Individualized care and new treatments are expected to provide improved therapeutic possibilities and better healthcare.
Economic costs and an aging population
On the national level, the costs of brain-related diseases have been growing for several decades. Western lifestyles as well as numerous known and unknown factors have increased the prevalence of neurological diseases. An aging population and an increase in life expectancy mean that the costs of treating neurological diseases will continue to grow.
Read moreEconomic costs and an aging population
New cures for patients
The aim of neuroscience research is primarily to produce new and more effective therapies for the patient, at a faster and more efficient pace.
Personalized healthcare on the horizon
The goal of research and product development is to improve our understanding of disease mechanisms in order to prevent the onset of neurological diseases, enable their early identification, and develop targeted, individualized therapies.